Comparison of Parameters Between a Frameless Brain Biopsy Method and the Standard Frame-based Stereotactic Biopsy
Comparison of Efficacy, Safety, Duration and Postoperative Hospitalization Between a Frameless Fiducial-less Brain Biopsy Method and the Standard Frame-based Stereotactic Biopsy
1 other identifier
interventional
56
0 countries
N/A
Brief Summary
The purpose of the present study is to compare the characteristics, i.e. efficacy, duration, safety and hospital stay, of a frameless fiducial-less brain biopsy method with those of the standard frame-based stereotactic technique. Inclusion criteria: adult patients with cerebral lesions: 1) for whom no conclusive diagnosis could be settled in a noninvasive manner; and 2a) who also had surgically inaccessible lesions (or involving eloquent areas), or multifocal lesions, or lesions for which the probable diagnosis is a contraindication for craniotomy, or 2b) were too ill or too old for open craniotomy. Type of Intervention: standard frame-based stereotactic brain biopsy technique or frameless fiducial-less method using an optical based navigation system and a mini frame apparatus - trajectory guide.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2012
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 23, 2016
CompletedFirst Posted
Study publicly available on registry
March 30, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedJuly 29, 2016
July 1, 2016
2.9 years
March 23, 2016
July 28, 2016
Conditions
Outcome Measures
Primary Outcomes (2)
Diagnostic result
Diagnostic yield, Histological - cytological evaluation of the biopsy specimens
One month postoperatively
Complications
Neurologic morbidity, New abnormal findings in the postoperative head CT scan
One month postoperatively
Secondary Outcomes (2)
Length of hospitalization
One month postoperatively
Duration of the whole procedure or steps
Immediately postoperatively
Study Arms (2)
Frame-based stereotactic brain biopsy
ACTIVE COMPARATORBrain biopsy
Frameless fiducial-less brain biopsy
ACTIVE COMPARATORBrain biopsy
Interventions
Brain biopsy using either the frame-based stereotactic technique, or a frameless fiducial-less brain biopsy method using an optical based navigation system and a mini frame apparatus - trajectory guide.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY DIRECTOR
Constantine Constantoyannis, MD, PhD
Department of Neurosurgery, University Hospital of Patras, Faculty of Medicine, University of Patras
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
March 23, 2016
First Posted
March 30, 2016
Study Start
January 1, 2012
Primary Completion
December 1, 2014
Study Completion
April 1, 2016
Last Updated
July 29, 2016
Record last verified: 2016-07
Data Sharing
- IPD Sharing
- Will not share